Celiac Disease Research News

Stay up to date on advances in the development of alternative, non-dietary treatments in the celiac disease field. These articles from the Beyond Celiac Research News feed highlight the latest news and past milestones in the journey to find new treatments – or even a cure – for celiac disease. Note:  Prior to December 2015, Beyond Celiac was known as the National Foundation for Celiac Awareness. Learn more about the name change here.  
09/06/2016

Up to Half of Patients May Not Fully Respond to a Gluten-Free Diet

Drug to treat non-responsive and refractory celiac disease being tested

09/01/2016

Landmark Meeting Identifies Pathway for New Celiac Disease Therapies

Beyond Celiac developing technology to bring stakeholders together

08/08/2016

The Search for Treatment Beyond the Gluten-Free Diet

New research shows promise in turning off the immune response to gluten in those with celiac disease

07/06/2016

Newly Diagnosed ​with Celiac Disease ​and Living in New England? Advance​ Research in One Simple Step

Researchers are working on an experimental new drug for celiac disease.

05/23/2016

New Research Study for Refractory Celiac Disease Looking for Participants

A research study is testing an investigational medication called AMG 714 for people with refractory celiac disease type II.

05/12/2016

Celimmune Commences First-Ever Dosing with AMG 714 in Celiac Disease

A new clinical trial for celiac disease is underway.

03/31/2016

Celimmune Commences Screening in Phase 2 Clinical Study in Refractory Celiac Disease Type II

Multinational study to evaluate the potential of Anti-IL-15 antibody, AMG 714, to treat rare in situ small bowel T cell ymphoma.

03/17/2016

ImmunogenX Acquires the Assets of Alvine Pharmaceuticals

Glutenase for in-vivo gluten degradation is a leading candidate for celiac disease

03/03/2016

Innovate Biopharmaceuticals Completes License For Late-Stage Celiac Disease Asset From Alba Therapeutics

Promising compound to begin phase 3 clinical trials for treatment of celiac disease.

09/03/2015

Journal Gastroenterology Publishes Research Indicating Nearly Identical Response to Gluten in Most Children and Adults with Celiac Disease

Research to inform therapeutic and diagnostic development for patients of all ages

06/22/2015

Cour Pharmaceuticals Releases Data on Potential Breakthrough Treatment for Celiac Disease

Cour Pharmaceuticals discusses recent study data the the 16th International Celiac Disease Symposium (ICDS).

05/20/2015

One Step Closer to New Treatment Options for Celiac Disease

Sanofi and Selecta Biosciences, Inc. collaborate on new immunotherapy for celiac disease.

03/02/2015

Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen

Company to develop AMG 714 for the treatment of diet non-responsive celiac disease and refractory celiac disease (celiac disease-triggered T-cell lymphoma).

02/23/2015

Celimmune Founded to Develop Novel Therapeutics for Celiac and Other Serious Autoimmune Diseases

Emerging therapeutic company to initially focus on addressing the significant medical and socioeconomic needs of patients with celiac disease

02/17/2015

Larazotide Acetate Shows Promising Results in Patients on Gluten-Free Diet with Persistent Symptoms

Although more research is needed, larazotide acetate may work better than the gluten-free diet alone in some patients.

11/21/2014

ImmusanT Recognized for Potential Celiac-Curing Vaccine

11/21/2014

Journal of Autoimmunity Publishes Research Supporting Safety of Oats in the Celiac Diet

Research Offers Benchmark of T Cell Reactivity by Comparing Side-by-Side Reactions to Barley and Oats in Celiac Disease Patients

05/13/2014

Gluten-Free Diet is Not Enough – Ongoing Intestinal Damage in Most Diagnosed Patients

Many people with celiac disease have significant disease-associated symptoms and intestinal damage despite trying to adhere to a strict gluten-free diet.

04/14/2014

Research Shows Promise for a Potential Future Treatment for Celiac Disease

Researchers have discovered that a human protein called elafin may be helpful in protecting against the inflammatory reaction seen in people with celiac disease.

02/11/2014

Alba Therapeutics Announces Positive Results of Phase IIb Trial in Celiac Disease

Alba Therapeutics Corporation provides an update on their investigational medication, larazotide acetate.

01/17/2014

National Study to Help Advance Celiac Disease Research

10/29/2013

Alvine Pharmaceuticals Doses First Patient in Phase 2B Trial for ALV003 in Celiac Disease

Alvine Pharmaceuticals, Inc. provides an update on a clinical trial investigating a potential medication for celiac disease.

08/21/2013

Fusion Antibodies Announces Collaboration For New Refractory Celiac Disease Drug With Calypso Biotech

Fusion Antibodies Ltd have announced a collaboration with Swiss biotech company Calypso Biotech for development of their CALY-002 Antibody.

08/12/2013

ImmusanT Begins Clinical Research Study to Explore Immunologic Relationship between Celiac Disease & Type 1 Diabetes

Study seeks to learn more about the relationship between the autoimmune diseases and the underlying cause of type 1 diabetes.

06/10/2013

Potential Pharmaceutical Treatments for Celiac Disease: An Interview with Joseph Murray, MD

Joseph Murray, MD of the Mayo Clinic explains the potential pharmaceutical treatments for celiac disease.

1 2 3 4
OUR PARTNERS